Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TBPH compared with AIV: revenue, margins and what each company keeps, and the suppliers and customers both name
TBPH
Theravance Biopharma, Inc.
Change
Mkt cap
Revenue
Revenue
AIV
Apartment Investment & Management Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
TBPH
Theravance Biopharma, Inc.
vs
AIV
Apartment Investment & Management Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TBPH
6
VTRS
Viatris
supplier
LAZ
Lazard
supplier
GSK
GSK
customer
RPRX
Royalty Pharma Investments
customer
2 more · TBPH chain
›
Shared
0
No disclosed counterparties: AIV.
Only AIV
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
TBPH
Theravance Biopharma, Inc.
Change
17.04
▲
+0.06%
Mkt cap
$884.2M
Revenue
$21M
Q2 FY26
Revenue
$107M
FY25
AIV
Apartment Investment & Management Co
Change
1.58
▼
−0.25%
Regular session
Nov 6 '26
Mkt cap
$229.5M
Revenue
$35M
Q3 FY25
Revenue
$138M
FY24
vs
Compare
Regular session
Nov 6 '26
TBPH
Theravance Biopharma, Inc.
vs
AIV
Apartment Investment & Management Co
17.04
▲
+0.06%
Price
1.58
▼
−0.25%
$884.2M
Mkt cap
$229.5M
Q2 FY26
$21M
Revenue
$35M
Q3 FY25
FY25
$107M
Revenue
$138M
FY24
Change
Change
TBPH
17.04
▲
+0.06%
vs
AIV
1.58
▼
−0.25%
Regular session
Nov 6 '26